Last reviewed · How we verify
CKD-391
At a glance
| Generic name | CKD-391 |
|---|---|
| Sponsor | Chong Kun Dang Pharmaceutical |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2) (PHASE1)
- A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391 (PHASE1)
- A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia (PHASE3)
- Compare the Pharmacokinetics and Safety of CKD-391 (PHASE1)
- Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337 (PHASE1)
- CKD-391 Pharmacokinetic Study Phase I (PHASE1)
- CKD-391 Pharmacokinetic Study (PHASE1)
- Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |